Related Experiment Video
Updated: May 8, 2026
Development of Amelogenin-chitosan Hydrogel for In Vitro Enamel Regrowth with a Dense Interface
Published on: July 10, 2014
Prosthodontic management of patients with amelogenesis imperfecta
V J Hoods-Moonsammy1, M M Mothopi, A K Taruvingira
1Department of Prosthodontics, School of Oral Health Science, Faculty of Health Sciences, University of the Witwatersrand. Vyonne.Hoods-Moonsammy@wits.ac.za
Introduction:
Amelogenesis Imperfecta (AI) is an heterogenous genetic disorder that disturbs the developing enamel structure. This rare ectodermal defect leads to a variety of clinical manifestations due to agenesis, hypoplasia, and/or hypomineralisation of the enamel.
Aims And Objectives:
To describe the prosthodontic management of dental anomalies commonly associated with AI.
Methods:
By using the classification of Witkop and Rao (1971), the variation in clinical presentation of the different Types of AI are illustrated and discussed, in particular Type I AI and Type 4 AI.
Results And Conclusions:
Early diagnosis and prosthodontic management as part of a multidisciplinary, patient-centred approach are key factors to treatment success. Treatment options to address the oral complications are influenced by modifying factors including age, socioeconomic status, type and severity of the disorder, and intraoral status at the time of treatment planning. Ultimately, management includes pain and infection control, provision of aesthetics and restoration of function which may lead to patient satisfaction, psychological well-being and an improved quality of life.
